Results 211 to 220 of about 86,908 (330)
British Journal of Clinical Pharmacology, EarlyView.Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan. [PDF]
JCO Precis OncolOgura N +10 more
europepmc +1 more source
Analysis of Rectal Neoplasms Operated After Neoadjuvant Therapy in A Period of 10 Years
, 2020 Humberto Fenner Lyra +6 more
openalex +2 more sources
Prognosis and Risk Factors in Patients With Non-radical Circumferential Resection Margin After Rectal Cancer Surgery. [PDF]
In VivoEhrnrooth B +3 more
europepmc +1 more source
Size matters: Establishing a cut‐off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines [PDF]
Seijong Kim +11 more
openalex +1 more source
Transanal minimally invasive surgery (TAMIS) for local excision of selected rectal neoplasms: efficacy and outcomes in the first 11 patients [PDF]
, 2014 Gustavo Sevá‐Pereira +5 more
openalex +1 more source
An Investigation of Hyperostosis Frontalis Interna in a Modern Anatomical Body Donor Population
Clinical Anatomy, EarlyView.ABSTRACT This research sought to examine the prevalence and severity of hyperostosis frontalis interna (HFI) in the Chicagoland anatomical body donor population. The study further aimed to elucidate potential demographic risk factors for HFI, including sex, age at death, and structural vulnerability index (SVI), as well as any common comorbidities, as ...
Amy C. Beresheim, Amanda Hall
wiley +1 more source